A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Clinical trial NCT05057013 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05057013
Sponsor: Cancer Research UK
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Triple Negative Breast Cancer Castration-resistant Prostate Cancer Cervical Cancer RAS Wild Type Colorectal Cancer Endometrial Cancer Gastric Cancer Hepatocellular Carcinoma (HCC)Melanoma Non-small Cell Lung Cancer (NSCLC)Oesophageal Cancer Ovarian Cancer

Start date: 2021-11-10
Primary completion: 2025-11-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.